PMDA inspection

Novartis Pharmaceutical Manufacturing GmbH

PMDA inspection 5130708009876 · Austria · Suitable

Key facts

Control number 5130708009876
Manufacturing site Novartis Pharmaceutical Manufacturing GmbH
Location Biochemiestrasse 10, 6336 Langkampfen, Austria
Country Austria
Product type Pharmaceuticals
Application type Regular
Inspection method Remote
Inspection month May 1, 2025
Result Suitable
Result notified May 15, 2025
PMDA registration AG22500031

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)